comparemela.com

Latest Breaking News On - Kent leyde - Page 1 : comparemela.com

Cadence Neuroscience raises $26M for epilepsy neuromod therapy

Neurmodulation technology developer Cadence Neuroscience announced that it secured $26 million in a Series B financing round.

Kent leydeKevin chuGerry brunkSpectrum financial servicesAngelini lumira biosciences fundCadence neuroscienceF prime capitalLivanova united statesAngelini venturesJazz venture partnersPaolo di giorgioMayo clinic

Cadence Neuroscience Raises $26M in Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesKevin chuGerry brunkKent leydeGregory worrellSpectrum financial servicesAngelini lumira biosciences fundCadence neuroscienceLumira venturesAngelini venturesF prime capitalMayo clinicMayo clinic neurology

Cadence Neuroscience Secures $26 Million in Series B Financing for Clinical Trials of Epilepsy Neuromodulation Therapy

/PRNewswire/ Cadence Neuroscience announced today that it has secured $26 million in Series B financing. The round was led by Angelini Lumira Biosciences.

United statesBritish columbiaKevin chuGregory worrellKent leydeGerry brunkAngelini lumira biosciences fundSpectrum financial servicesAngelini industriesLumira venturesAngelini venturesF prime capitalLivanova united statesMayo clinicMayo clinic neurologyChief executive

vimarsana © 2020. All Rights Reserved.